[posting]58918755[/posting]Published: Nov 6, 2018 7:14 a.m. ET
CVS Health Corp. shares rose 2.6% in Tuesday premarket trading after the pharmacy retailer reported third-quarter earnings and sales that beat consensus.
Net income totaled $1.39 billion, or $1.36 per share, up from $1.29 billion, or $1.26 per share, last year.
Adjusted EPS was $1.73. Revenue totaled $47.3 billion, up from $46.2 billion. And same-store sales rose 6.7% with pharmacy same-store sales up 8.7%.
The FactSet consensus was for EPS of $1.71, revenue of $47.2 billion, and same-store sales growth of 5.4%.
Pharmacy same-store sales were forecast to be up 7.6%.
CVS continues to expect full-year EPS of $1.40 to $1.50 and adjusted EPS of $6.98 to $7.08. The FactSet guidance is for EPS of $7.04....
=> P/E|2018e = ~USD76 / USD7.04 = ~10.8 --> nicht sehr teuer würde ich mal sagen
|aus der Diskussion:||AKTIEN IM FOKUS: Übernahme von Aetna setzen CVS-Health-Aktien unter Druck|
|Autor (Datum des Eintrages):||faultcode (06.11.18 13:51:35)|
|Beitrag:||15 von 34 (ID:59148543)|
|Alle Angaben ohne Gewähr © wallstreet:online|